Skip to main content
. 2024 Apr 29;13(5):368. doi: 10.3390/pathogens13050368

Table 2.

Prevalence of salivary Aa and LtxA-neutralizing antibodies positive individuals in the two analyzed study cohorts.

Saliva Aa Serum LtxA ab
Total Analyzed (Missing) Number Pos (%) Total Analyzed (Missing) Number Pos (%)
All 290 (7) 34 (11.7) 286 (11) 51 (17.8)
Blood donors 101 (0) 6 (5.9) 100 (1) 16 (16.0)
RA-cohort 189 (7) 28 (14.8) 186 (10) 35 (18.8)